CARTO

Cartography Biosciences is a precision immunology company dedicated to creating a comprehensive atlas of the cell surface to identify novel, highly specific therapeutic targets. By combining single-cell genomics, proteomics, and advanced computational analysis, the company maps the distribution of antigens across both healthy and diseased tissues to minimize off-target effects. Their platform enables the discovery of targets for various modalities, including CAR-T cell therapies and T-cell engagers, with an initial focus on oncology and immunology. Founded by pioneers in genomics and cell therapy, Cartography aims to overcome the limitations of current immunotherapies by expanding the library of actionable targets beyond well-known markers like CD19.